OBJECTIVE: To study the prevalence of cervical squamous intraepithelial lesions (SILs) and their association with HIV-1 infection and immunodeficiency among pregnant women in Kigali, Rwanda. METHODS: As part of a cohort study on the impact of HIV-1 infection on pregnancy outcome, HIV-1 seropositive (HIV+) and seronegative (HIV-) pregnant women were enrolled during the last trimester of pregnancy at the maternity ward of the Centre Hospitalier de Kigali from July 1992 to August 1993. At inclusion, women were screened for sexually transmitted diseases (STDs)--syphilis, Neisseria gonorrhoeae, chlamydia trachomatis, Trichomonas vaginalis. CD4+ lymphocyte counts were measured and a Papanicolaou smear performed. RESULTS: Papanicolaou smear was interpretable in 103 HIV+ women and 107 HIV- women. Prevalence of SILs was significantly higher in HIV+ women than in HIV- women: 24.3% v 6.5% (odds ratio = 4.6; 95% CI: 1.8-12.3). SIL+ women (n = 32) tended to have more STDs than SIL- women (n = 178), but this did not reach a statistical difference: 37.5% and 24.7% respectively (p = 0.13). They also had a mean CD4 count significantly lower than SIL- women (623 and 784 CD4+ cells x 10(6)/l, respectively; p = 0.02). CONCLUSION: SILs were HIV related and the association with immunosuppression was statistically significant. Prevalence of SILs was high in this population of pregnant women with high HIV/STDs prevalence. Screening policy for STDs and SILs in African women should be assessed in prenatal care.
OBJECTIVE: To study the prevalence of cervical squamous intraepithelial lesions (SILs) and their association with HIV-1 infection and immunodeficiency among pregnant women in Kigali, Rwanda. METHODS: As part of a cohort study on the impact of HIV-1 infection on pregnancy outcome, HIV-1 seropositive (HIV+) and seronegative (HIV-) pregnant women were enrolled during the last trimester of pregnancy at the maternity ward of the Centre Hospitalier de Kigali from July 1992 to August 1993. At inclusion, women were screened for sexually transmitted diseases (STDs)--syphilis, Neisseria gonorrhoeae, chlamydia trachomatis, Trichomonas vaginalis. CD4+ lymphocyte counts were measured and a Papanicolaou smear performed. RESULTS: Papanicolaou smear was interpretable in 103 HIV+ women and 107 HIV- women. Prevalence of SILs was significantly higher in HIV+ women than in HIV- women: 24.3% v 6.5% (odds ratio = 4.6; 95% CI: 1.8-12.3). SIL+ women (n = 32) tended to have more STDs than SIL- women (n = 178), but this did not reach a statistical difference: 37.5% and 24.7% respectively (p = 0.13). They also had a mean CD4 count significantly lower than SIL- women (623 and 784 CD4+ cells x 10(6)/l, respectively; p = 0.02). CONCLUSION: SILs were HIV related and the association with immunosuppression was statistically significant. Prevalence of SILs was high in this population of pregnant women with high HIV/STDs prevalence. Screening policy for STDs and SILs in African women should be assessed in prenatal care.
Authors: V Leroy; J Ladner; M Nyiraziraje; A De Clercq; A Bazubagira; P Van de Perre; E Karita; F Dabis Journal: AIDS Date: 1998-04-16 Impact factor: 4.177
Authors: C L Langley; E Benga-De; C W Critchlow; I Ndoye; M D Mbengue-Ly; J Kuypers; G Woto-Gaye; S Mboup; C Bergeron; K K Holmes; N B Kiviat Journal: AIDS Date: 1996-04 Impact factor: 4.177
Authors: G La Ruche; B You; I Mensah-Ado; C Bergeron; C Montcho; R Ramon; K Touré-Coulibaly; C Welffens-Ekra; F Dabis; G Orth Journal: Int J Cancer Date: 1998-05-18 Impact factor: 7.396
Authors: A R Feingold; S H Vermund; R D Burk; K F Kelley; L K Schrager; K Schreiber; G Munk; G H Friedland; R S Klein Journal: J Acquir Immune Defic Syndr (1988) Date: 1990
Authors: A Chao; M Bulterys; F Musanganire; P Habimana; P Nawrocki; E Taylor; A Dushimimana; A Saah Journal: Int J Epidemiol Date: 1994-04 Impact factor: 7.196
Authors: P G Motti; G A Dallabetta; R W Daniel; J K Canner; J D Chiphangwi; G N Liomba; L Yang; K V Shah Journal: J Infect Dis Date: 1996-03 Impact factor: 5.226
Authors: Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt Journal: AIDS Date: 2018-07-01 Impact factor: 4.177
Authors: Groesbeck P Parham; Vikrant V Sahasrabuddhe; Mulindi H Mwanahamuntu; Bryan E Shepherd; Michael L Hicks; Elizabeth M Stringer; Sten H Vermund Journal: Gynecol Oncol Date: 2006-07-27 Impact factor: 5.482
Authors: Julius Atashili; Adaora A Adimora; Peter M Ndumbe; George M Ikomey; Allen C Rinas; Evan Myers; Joseph Eron; Jennifer S Smith; William C Miller Journal: Cancer Epidemiol Date: 2011-11-01 Impact factor: 2.984
Authors: Diljeet K Singh; Kathryn Anastos; Donald R Hoover; Robert D Burk; Qiuhu Shi; Louis Ngendahayo; Eugene Mutimura; Antonio Cajigas; Venerand Bigirimani; Xiaotao Cai; Janvier Rwamwejo; Magalis Vuolo; Mardge Cohen; Philip E Castle Journal: J Infect Dis Date: 2009-06-15 Impact factor: 5.226
Authors: Annie J Sasco; Antoine Jaquet; Emilie Boidin; Didier K Ekouevi; Fabian Thouillot; Thomas Lemabec; Marie-Anna Forstin; Philippe Renaudier; Paul N'dom; Denis Malvy; François Dabis Journal: PLoS One Date: 2010-01-11 Impact factor: 3.240
Authors: Innocent O Maranga; Lynne Hampson; Anthony W Oliver; Xiaotong He; Peter Gichangi; Farzana Rana; Anselmy Opiyo; Ian N Hampson Journal: Open Virol J Date: 2013-02-25
Authors: Uzoma Ononogbu; Maryam Almujtaba; Fatima Modibbo; Ishak Lawal; Richard Offiong; Olayinka Olaniyan; Patrick Dakum; Donna Spiegelman; William Blattner; Clement Adebamowo Journal: BMC Public Health Date: 2013-06-14 Impact factor: 3.295